In June, we participated to the 4th Drug Development Summit in Switzerland and one of
our objective was to collect new information on the way to conduct R&D in the Pharmaceutical industry, Biotech. companies and also the management of pre-clinical R&D.
During this congress we had more than 25 Face-to-Face meetings with big pharma like Novartis, Sanofi, UCB and also Biotech and mid-size pharma like Helsinn, ADDEX… It is an important congress for us to have a feedback from o...
You'll find Syncrosome last publication in the Gastrointestinal field: "Inflence of tachykinin NK2 receptors on intestinal sensitivity and motility in newborn rats" (pdf)
Syncrosome download section:
Nota bene : depending on whether
you are identified or not, you have access to a more or less rich content !
Download our booklets:
SYNCROSOME: Preclinical presentation
CARDIOVASCULAR: models efficacy and safety assessment
NEURODEGENRATIVE DISORDERS: Central nervous system models
Syncrosome is a Preclinical Drug Evaluation Company specialised in human and animal health in vivo pharmacological studies. Syncrosome has the professional expertise to complete studies independently or to work in parallel with in-house research teams, after preliminary in vitro screenings - www.syncrosome.com